UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000042404
Receipt number R000048404
Scientific Title Effect of Daily Ingestion of test beverage containing extract of koji-fermented food on improving physical-mental minor complaints: A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study
Date of disclosure of the study information 2020/11/10
Last modified on 2021/04/15 13:51:51

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effect of Daily Ingestion of test beverage containing extract of koji-fermented food on improving physical-mental minor complaints: A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study

Acronym

Effect of Daily Ingestion of test beverage containing extract of koji-fermented food on improving physical-mental minor complaints

Scientific Title

Effect of Daily Ingestion of test beverage containing extract of koji-fermented food on improving physical-mental minor complaints: A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study

Scientific Title:Acronym

Effect of Daily Ingestion of test beverage containing extract of koji-fermented food on improving physical-mental minor complaints

Region

Japan


Condition

Condition

Healthy Adult

Classification by specialty

Not applicable Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Comprehensive search for clinical benefits associated with 4 weeks daily intake of test beverage containing extract of koji-fermented food on improving physical-mental minor complaints.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

VAS questionnaire after 4 weeks of intake of test beverage

Key secondary outcomes

Heart rate variability, electroencephalogram during sleeping, sleeping record, survey on subjects' sleeping and mental and physical conditions


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

Placebo

Stratification


Dynamic allocation

NO

Institution consideration


Blocking


Concealment

Central registration


Intervention

No. of arms

2

Purpose of intervention

Prevention

Type of intervention

Food

Interventions/Control_1

Daily ingestion 170 ml of test beverage containing extract of koji-fermented food for 4 weeks.

Interventions/Control_2

Daily ingestion 170 ml of placebo beverage for 4 weeks.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

30 years-old <=

Age-upper limit

65 years-old >

Gender

Female

Key inclusion criteria

1. Subjects who agree to participate in this study with a written informed consent.
2. Subjects with physical-mental minor complaints.

Key exclusion criteria

1. Subjects with a clinical history of gastrointestinal cancer or currently under treatment or anti-tumor medication.
2. Subjects with gastrointestinal disorders such as inflammatory bowel syndrome, irritable bowel syndrome, etc.
3. Subjects under iron reduction therapy.
4. Subjects with serious cerebrovascular, cardiac, hepatic, renal, gastrointestinal diseases, and/or affected with infectious diseases requiring reports to the authorities.
5. Subjects with major surgical history relevant to the digestive system such as gastrectomy, gastrorrhaphy, enterectomy, etc.
6. Subjects with unusually high and/or low blood pressure, abnormal physical data and/or abnormal hematological data.
7. Subjects with severe anemia.
8. Pre- or post-menopausal women complaining of obvious physical changes.
9. Subjects who are at risk of having allergic reactions to drugs and/or foods especially koji.
10. Subjects who regularly take medicine, functional foods, and/or supplements which would affect bowel movements or intestinal environment.
11. Subjects who regularly take functional foods and/or supplements containg iron.
12. Subjects who regularly take koji and/or amazake 100 g/day.
13. Heavy smokers, alcohol addicts and/or subjects with disordered lifestyle.
14. Subjects who donated either 400 ml whole blood within 16 weeks, 200 ml whole blood within 4 weeks, or blood components within 2 weeks , prior to the current study.
15. Pregnant or lactating women or women who expect to be pregnant during this study.
16. Subjects who currently participate in other clinical trials, or participated within the last 4 weeks prior to the current study.
17. Any other medical and/or health reasons unfavorable to participation in the current study, as judged by the principal investigator.

Target sample size

20


Research contact person

Name of lead principal investigator

1st name Jun
Middle name
Last name NISHIHIRA

Organization

Hokkaido Information University

Division name

Department of Medical Management and Informatics

Zip code

069-8585

Address

59-2, Nishi-nopporo, Ebetsu, Hokkaido, 069-8585, Japan

TEL

011-385-4411

Email

nishihira@do-johodai.ac.jp


Public contact

Name of contact person

1st name Jun
Middle name
Last name NISHIHIRA

Organization

Hokkaido Information University

Division name

Health Information Science Center

Zip code

069-8585

Address

59-2, Nishi-nopporo, Ebetsu, Hokkaido, 069-8585, Japan

TEL

011-385-4430

Homepage URL


Email

nishihira@do-johodai.ac.jp


Sponsor or person

Institute

Hokkaido Information University

Institute

Department

Personal name



Funding Source

Organization

National Agriculture and Food Research Organization

Organization

Division

Category of Funding Organization

Government offices of other countries

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor

National Agriculture and Food Research Organization

Name of secondary funder(s)



IRB Contact (For public release)

Organization

The ethics committee of Hokkaido Information University

Address

59-2, Nishi-nopporo, Ebetsu, Hokkaido, 069-8585, Japan

Tel

011-385-4411

Email

soumu@do-johodai.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

北海道情報大学 保健センター(北海道)


Other administrative information

Date of disclosure of the study information

2020 Year 11 Month 10 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2020 Year 10 Month 28 Day

Date of IRB

2020 Year 10 Month 28 Day

Anticipated trial start date

2020 Year 11 Month 10 Day

Last follow-up date

2021 Year 02 Month 24 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2020 Year 11 Month 10 Day

Last modified on

2021 Year 04 Month 15 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000048404